Bloomberg
Colossal Biosciences Backer 81 Collection Raises Second Fund
Wednesday, November 11, 2026
The 81 Collection, a Chicago-based venture capital firm, closed its second fund at $82 million. The firm is an investor in Colossal Biosciences Inc., a de-extinction and synthetic biology company.
Original reporting:
